Chung‐Yuan Hsu

838 total citations
47 papers, 625 citations indexed

About

Chung‐Yuan Hsu is a scholar working on Rheumatology, Orthopedics and Sports Medicine and Surgery. According to data from OpenAlex, Chung‐Yuan Hsu has authored 47 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Rheumatology, 19 papers in Orthopedics and Sports Medicine and 11 papers in Surgery. Recurrent topics in Chung‐Yuan Hsu's work include Rheumatoid Arthritis Research and Therapies (16 papers), Bone health and osteoporosis research (15 papers) and Systemic Lupus Erythematosus Research (9 papers). Chung‐Yuan Hsu is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (16 papers), Bone health and osteoporosis research (15 papers) and Systemic Lupus Erythematosus Research (9 papers). Chung‐Yuan Hsu collaborates with scholars based in Taiwan, United States and France. Chung‐Yuan Hsu's co-authors include Tien‐Tsai Cheng, Yu‐Jih Su, Shan‐Fu Yu, Jia‐Feng Chen, Ying‐Chou Chen, Wen‐Chan Chiu, Han‐Ming Lai, Tien‐Hsing Chen, Hua‐Chien Chen and Yu‐Sheng Lin and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and International Journal of Molecular Sciences.

In The Last Decade

Chung‐Yuan Hsu

47 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chung‐Yuan Hsu Taiwan 15 242 195 146 143 119 47 625
Debby den Uyl Netherlands 13 330 1.4× 219 1.1× 121 0.8× 150 1.0× 106 0.9× 21 770
A. Krabben Netherlands 18 684 2.8× 98 0.5× 81 0.6× 58 0.4× 110 0.9× 26 862
Takeshi Nakatsue Japan 13 168 0.7× 171 0.9× 106 0.7× 78 0.5× 92 0.8× 42 593
J Pazdur Poland 9 627 2.6× 175 0.9× 143 1.0× 40 0.3× 215 1.8× 22 915
Agnès Guerci France 19 666 2.8× 463 2.4× 247 1.7× 52 0.4× 83 0.7× 49 2.1k
Dragomir Marisavljević Serbia 16 139 0.6× 119 0.6× 109 0.7× 14 0.1× 104 0.9× 69 650
Alessandra Cannizzaro Italy 11 365 1.5× 127 0.7× 69 0.5× 12 0.1× 396 3.3× 17 729
Fiona Maclean Australia 14 225 0.9× 195 1.0× 161 1.1× 13 0.1× 23 0.2× 59 826
Beáta Dérfalvi Canada 14 144 0.6× 193 1.0× 46 0.3× 15 0.1× 271 2.3× 37 644
Orianne Wagner‐Ballon France 17 49 0.2× 236 1.2× 40 0.3× 23 0.2× 157 1.3× 54 825

Countries citing papers authored by Chung‐Yuan Hsu

Since Specialization
Citations

This map shows the geographic impact of Chung‐Yuan Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chung‐Yuan Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chung‐Yuan Hsu more than expected).

Fields of papers citing papers by Chung‐Yuan Hsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chung‐Yuan Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chung‐Yuan Hsu. The network helps show where Chung‐Yuan Hsu may publish in the future.

Co-authorship network of co-authors of Chung‐Yuan Hsu

This figure shows the co-authorship network connecting the top 25 collaborators of Chung‐Yuan Hsu. A scholar is included among the top collaborators of Chung‐Yuan Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chung‐Yuan Hsu. Chung‐Yuan Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Shang‐Hung, Chung‐Yuan Hsu, & Sung‐Chou Li. (2024). Increased Circulating CD14+ Monocytes in Patients with Psoriatic Arthritis Presenting Impaired Apoptosis Activity. Biomedicines. 12(4). 775–775. 1 indexed citations
2.
Su, Yu‐Jih, Chun‐Yu Lin, & Chung‐Yuan Hsu. (2024). Analyzing the risk of osteoporosis and fracture in rheumatoid arthritis patients who have been treated with various biologics. International Journal of Rheumatic Diseases. 27(2). e15055–e15055. 3 indexed citations
3.
Hsu, Chung‐Yuan, et al.. (2024). Association of Decreased Bone Density and Hyperlipidemia in a Taiwanese Older Adult Population. Journal of the Endocrine Society. 8(5). bvae035–bvae035. 1 indexed citations
4.
Chen, Jia‐Feng, Shan‐Fu Yu, Wen‐Chan Chiu, et al.. (2024). Development and Comparison of Treatment Decision Tools for Glucocorticoid-Induced Osteoporosis. Diagnostics. 14(4). 452–452. 2 indexed citations
5.
Wang, Yuwei, Jia‐Feng Chen, Tien‐Tsai Cheng, et al.. (2023). Factors associated with subclinical inflammation of wrist joints in rheumatoid arthritis patients with low or no disease activity- a RA ultrasound registry study. BMC Musculoskeletal Disorders. 24(1). 438–438. 1 indexed citations
6.
Su, Yu‐Jih, Huiming Chen, Tien‐Tsai Cheng, et al.. (2023). Disease-modifying anti-rheumatic drugs associated with different diabetes risks in patients with rheumatoid arthritis. RMD Open. 9(3). e003045–e003045. 6 indexed citations
7.
Lin, Shang‐Hung, Ji‐Chen Ho, Sung‐Chou Li, et al.. (2022). TNF-α Activating Osteoclasts in Patients with Psoriatic Arthritis Enhances the Recruitment of Osteoclast Precursors: A Plausible Role of WNT5A-MCP-1 in Osteoclast Engagement in Psoriatic Arthritis. International Journal of Molecular Sciences. 23(2). 921–921. 9 indexed citations
8.
Lin, Chun‐Yu, et al.. (2022). Association of primary Sjögren’s syndrome with incident heart failure: a secondary analysis of health claims data in Taiwan. Therapeutic Advances in Chronic Disease. 13. 374126659–374126659. 4 indexed citations
9.
Hsu, Chung‐Yuan, et al.. (2022). Prolonged peripheral seronegative spondyloarthritis following BioNTech coronavirus disease 2019 vaccination: A case report. International Journal of Rheumatic Diseases. 26(4). 774–777. 4 indexed citations
10.
Tsai, Pei‐Shan, et al.. (2022). Plasmapheresis for a Patient with Catatonia and Systemic Lupus Erythematosus: A Case Report and Literature Review. Journal of Clinical Medicine. 11(22). 6670–6670. 2 indexed citations
11.
Yu, Shan‐Fu, Ming‐Han Chen, Jia‐Feng Chen, et al.. (2022). Establishment of a preliminary FRAX®-based intervention threshold for rheumatoid arthritis–associated fragility fracture: a 3-year longitudinal, observational, cohort study. Therapeutic Advances in Chronic Disease. 13. 374126665–374126665. 5 indexed citations
12.
Yu, Shan‐Fu, Jia‐Feng Chen, Ying‐Chou Chen, et al.. (2022). The Impact of Seropositivity on Systemic Bone Loss in Rheumatoid Arthritis—A 3-Year Interim Analysis of a Longitudinal Observational Cohort Study. Frontiers in Medicine. 9. 885801–885801. 2 indexed citations
13.
Lin, Chun‐Yu, et al.. (2021). Time‐Dependent Analysis of Risk of New‐Onset Heart Failure Among Patients With Polymyositis and Dermatomyositis. Arthritis & Rheumatology. 74(1). 140–149. 6 indexed citations
14.
Hsu, Chung‐Yuan, Yu‐Jih Su, Jia‐Feng Chen, et al.. (2021). Patients With Rheumatoid Arthritis With an Inadequate Response to Disease‐Modifying Antirheumatic Drugs at a Higher Risk of Acute Coronary Syndrome. Journal of the American Heart Association. 10(8). e018290–e018290. 7 indexed citations
15.
Chen, Ming‐Han, Shan‐Fu Yu, Jia‐Feng Chen, et al.. (2021). Different Effects of Biologics on Systemic Bone Loss Protection in Rheumatoid Arthritis: An Interim Analysis of a Three-Year Longitudinal Cohort Study. Frontiers in Immunology. 12. 783030–783030. 11 indexed citations
16.
Hsu, Chung‐Yuan, Ying‐Chou Chen, You‐Yin Chen, et al.. (2021). Simple Self-Assessment Tool to Predict Osteoporosis in Taiwanese Men. Frontiers in Medicine. 8. 713535–713535. 3 indexed citations
17.
Hsu, Chung‐Yuan, Jia‐Feng Chen, Yu‐Jih Su, et al.. (2020). Time-averaged disease activity of rheumatoid arthritis associated with long-term bone mineral density changes. Therapeutic Advances in Chronic Disease. 11. 1754273293–1754273293. 7 indexed citations
18.
Hsu, Chung‐Yuan, Ming‐Shyan Lin, Yu‐Jih Su, et al.. (2016). Cumulative immunosuppressant exposure is associated with diversified cancer risk among 14 832 patients with systemic lupus erythematosus: a nested case–control study. Lara D. Veeken. 56(4). kew457–kew457. 52 indexed citations
19.
Chen, Jia‐Feng, Shan‐Fu Yu, Wen‐Chan Chiu, et al.. (2015). Development and Validation of an Osteoporosis Self-Assessment Tool for Taiwan (OSTAi) Postmenopausal Women-A Sub-Study of the Taiwan OsteoPorosis Survey (TOPS). PLoS ONE. 10(6). e0130716–e0130716. 20 indexed citations
20.
Su, Yu‐Jih, Tien‐Tsai Cheng, Chung‐Jen Chen, et al.. (2013). The association among leukocyte apoptosis, autoantibodies and disease severity in systemic lupus erythematosus. Journal of Translational Medicine. 11(1). 261–261. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026